selected publications
-
Metabolic adaptation drives arsenic trioxide resistance in acute promyelocytic leukemia.
Blood advances.
2022
Academic Article
GET IT
Times cited: 2 -
Microenvironment and drug resistance in acute myeloid leukemia: Do we know enough?.
International journal of cancer.
2021
Review
GET IT
Times cited: 4 -
Management of relapse in acute promyelocytic leukaemia treated with up-front arsenic trioxide-based regimens.
British journal of haematology.
2020
Academic Article
GET IT
Times cited: 12 -
A phase II study evaluating the role of bortezomib in the management of relapsed acute promyelocytic leukemia treated upfront with arsenic trioxide.
Cancer medicine.
2020
Academic Article
GET IT
Times cited: 11 -
Combination Lenalidomide/Bortezomib Treatment Synergistically Induces Calpain-Dependent Ikaros Cleavage and Apoptosis in Myeloma Cells.
Molecular cancer research : MCR.
2020
Academic Article
GET IT
Times cited: 7 -
Stromal cells downregulate miR-23a-5p to activate protective autophagy in acute myeloid leukemia.
Cell death & disease.
2019
Academic Article
GET IT
Times cited: 24 -
Prevalence of FVIII inhibitors in severe haemophilia A patients: Effect of treatment and genetic factors in an Indian population.
Haemophilia : the official journal of the World Federation of Hemophilia.
2018
Academic Article
GET IT
Times cited: 7 -
Arsenic Trioxide Enhances the NK Cell Cytotoxicity Against Acute Promyelocytic Leukemia While Simultaneously Inhibiting Its Bio-Genesis.
Frontiers in immunology.
2018
Academic Article
GET IT
Times cited: 493 -
Rationale and efficacy of proteasome inhibitor combined with arsenic trioxide in the treatment of acute promyelocytic leukemia.
Leukemia.
2016
Academic Article
GET IT
Times cited: 25 -
Comparison of newly diagnosed and relapsed patients with acute promyelocytic leukemia treated with arsenic trioxide: insight into mechanisms of resistance.
PloS one.
2015
Academic Article
GET IT
Times cited: 36 -
Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapy.
Blood.
2012
Academic Article
GET IT
Times cited: 42